| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0025-7753(02)73546-X |
| P698 | PubMed publication ID | 12459109 |
| P50 | author | Josep Font | Q73474655 |
| Miguel Ingelmo | Q73600642 | ||
| P2093 | author name string | Sònia Jiménez | |
| P2860 | cites work | Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 |
| Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus | Q28319260 | ||
| The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators | Q29614947 | ||
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Cardiovascular risk factors and the long-term outcome of lupus nephritis | Q31846096 | ||
| Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome | Q33327909 | ||
| Beta2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels | Q33328443 | ||
| Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus | Q33329033 | ||
| Lupus erythematosus in the 1980s: a survey of 570 patients | Q33384712 | ||
| Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death | Q33403579 | ||
| How accelerated atherosclerosis in SLE has changed our management of the disorder | Q33915484 | ||
| Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. | Q33974321 | ||
| Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
| Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. | Q35171679 | ||
| Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis | Q36747001 | ||
| Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production | Q37354525 | ||
| The natural history of systemic lupus erythematosus by prospective analysis | Q39866953 | ||
| The oxidation hypothesis of atherosclerosis | Q40625668 | ||
| Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
| Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages | Q73149303 | ||
| Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1beta | Q73541937 | ||
| Immunology, lupus and atheroma | Q73775676 | ||
| Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus | Q73904664 | ||
| Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction | Q73965948 | ||
| Hydroxychloroquine: past, present, future | Q74440678 | ||
| Progression of coronary artery calcification: a pilot study | Q77378115 | ||
| Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies? | Q77492467 | ||
| Beta2-glycoprotein I as a 'cofactor' for anti-phospholipid reactivity with endothelial cells | Q77549919 | ||
| Atherosclerosis and the antiphospholipid syndrome: a link unravelled? | Q77549999 | ||
| Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus | Q77909409 | ||
| Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. | Q40882910 | ||
| Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study | Q40906633 | ||
| Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovascular disease | Q41288539 | ||
| Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 | ||
| Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids | Q41943371 | ||
| Expression of functional CD40 by vascular endothelial cells | Q41981036 | ||
| The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 | ||
| Risk factors for cardiovascular disease in systemic lupus erythematosus | Q43767819 | ||
| The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients | Q44593960 | ||
| Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study | Q45221518 | ||
| Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland | Q48660184 | ||
| Inflammation, atherosclerosis, and ischemic events -- exploring the hidden side of the moon. | Q48731138 | ||
| Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. | Q49209737 | ||
| Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. | Q50950290 | ||
| Reproducibility of extracranial carotid atherosclerotic lesions assessed by B-mode ultrasound: the Atherosclerosis Risk in Communities Study. | Q50991511 | ||
| Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery. The Rotterdam Study. | Q51014269 | ||
| Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. | Q51577475 | ||
| Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. | Q51578946 | ||
| Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. | Q51590158 | ||
| Natural statins and stroke risk. | Q54269454 | ||
| Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging | Q56554483 | ||
| Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome | Q60627451 | ||
| Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus | Q60680877 | ||
| Chylomicron metabolism is markedly altered in systemic lupus erythematosus | Q61974594 | ||
| Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus | Q66915596 | ||
| Risk factors for coronary artery disease in patients with systemic lupus erythematosus | Q67586359 | ||
| Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group | Q68022503 | ||
| Measurement variability in duplex scan assessment of carotid atherosclerosis | Q68093507 | ||
| Carotid and lower extremity arterial disease in elderly adults with isolated systolic hypertension | Q68185260 | ||
| Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study | Q68541427 | ||
| Ischemic heart disease in systemic lupus erythematosus. A retrospective study of 65 patients treated with prednisolone | Q69387458 | ||
| Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids | Q69414146 | ||
| Systemic lupus erythematosus and acute myocardial infarction | Q69604022 | ||
| Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus | Q69745178 | ||
| A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death | Q70245059 | ||
| Dyslipoproteinemia in pediatric systemic lupus erythematosus | Q70396550 | ||
| Coronary arteritis, occlusion, and myocardial infarction due to lupus erythematosus | Q70447567 | ||
| Coronary arterial disease in systemic lupus erythematosus; quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years | Q70715027 | ||
| Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial | Q71512983 | ||
| Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study | Q71730400 | ||
| Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort | Q71781140 | ||
| Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors | Q72049303 | ||
| Inflammation and coronary artery disease | Q72071558 | ||
| Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus | Q72214273 | ||
| Vitamin status and intake as primary determinants of homocysteinemia in an elderly population | Q72305071 | ||
| Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men | Q72369034 | ||
| Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus | Q72607855 | ||
| Ultrasound-determined intima-media thickness and atherosclerosis. Direct and indirect validation | Q72767053 | ||
| Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis | Q72848390 | ||
| Antibody against oxidized low-density lipoprotein predicting myocardial infarction | Q72855306 | ||
| Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study | Q73089828 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | Spanish | Q1321 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 699-706 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Medicina clínica | Q26854009 |
| P1476 | title | Systemic lupus erythematosus and cardiovascular disease | |
| P478 | volume | 119 |
Search more.